The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp737
PANEL DISCUSSION
Date
May 8, 2023
Explore related products in the following collection:
This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved. We will discuss AGA advocacy priorities, a model for removing barriers to high-value care in inflammatory bowel disease and GI, and how to most effectively engage in collaborative advocacy on behalf of the GI community.
INTRODUCTION: A number of medications have been implicated as primary risk factors for microscopic colitis (MC) and guidelines recommend discontinuation of these medications as part of MC management…
This session is designed to demonstrate successful quality improvement in practices and across institutions with the focus on and meaningful real world implementation across a range of GI conditions…
This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice…